Frontlight ResearchEarly access
Childhood cancers trials in China
609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleHaplo-cord HCT vs. Haplo-HCT for T-ALL Patients
- Where
- Suzhou
- People
- 146
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06381817 - Early phase 1Taking peopleAnti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.
- Where
- Shanghai
- Age
- 18 weeks to 70 weeks
- People
- 12
- Run by
- Shanghai Tongji Hospital, Tongji University School of Medicine
See details and how to joinNCT06375161 - No phaseTaking peopleImmune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
- Where
- Mianyang, Yangchun
- Age
- 9 years to 45 years
- People
- 600
- Run by
- Shanghai Bovax Biotechnology Co., Ltd.
See details and how to joinNCT05371353 - No phaseTaking peopleCD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+
- Where
- Tianjin
- Age
- 3 years to 18 years
- People
- 60
- Run by
- Zhu Xiaofan
See details and how to joinNCT06355739 - Phase 2Taking peopleRDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.
- Where
- Suzhou
- Age
- 15 years to 65 years
- People
- 124
- Run by
- Chen Suning
See details and how to joinNCT06250959 - Phase 1Taking peopleWeekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
- Where
- Beijin, Beijing, Jina
- Age
- 8 years to 40 years
- People
- 44
- Run by
- Peking University People's Hospital
See details and how to joinNCT06340204 - Phase 1Taking peopleHS-IT101 Injection in the Treatment of Advanced Solid Tumors
- Where
- Beijing
- Age
- 18 days to 75 days
- People
- 44
- Run by
- Hangzhou Huasai Biomedicine Co., Ltd.
See details and how to joinNCT06342336 - Phase 4Taking peopleBlinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
- Where
- Zhenzhou
- Age
- Up to 65 years
- People
- 60
- Run by
- Suping ZHANG
See details and how to joinNCT06339775 - No phaseTaking peopleNarlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells
- Where
- Beijing
- Age
- 8 years and over
- People
- 60
- Run by
- Peking University People's Hospital
See details and how to joinNCT06302465 - Phase 2Taking peopleA Randomized Controlled Study Evaluating Modified Cup Anteversion Placement in Prevention of Postoperative Dislocation in Patients Undergoing Acetabular Tumor Resection and Reconstruction
- Where
- Ningbo
- Age
- 16 years and over
- People
- 118
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05593146 - Early phase 1Taking people18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
- Where
- Beijing
- Age
- 1 year to 80 years
- People
- 150
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT05069220 - No phaseTaking peopleAI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
- Where
- Guangzhou
- People
- 4,000
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06286267 - Phase 1Taking peopleOncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
- Where
- Beijing
- Age
- 1 year to 18 years
- People
- 18
- Run by
- Capital Medical University
See details and how to joinNCT05717699 - Phase 1Taking peopleOncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
- Where
- Beijing
- Age
- 1 year to 18 years
- People
- 18
- Run by
- Capital Medical University
See details and how to joinNCT05717712 - Phase 3Not yet taking people in ChinaThe Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma
- Where
- Shanghai
- Age
- 14 years to 70 years
- People
- 142
- Run by
- Ruijin Hospital
See details and how to joinNCT06255795 - No phaseTaking peopleThe Maintenance Treatment of "ITIVA" in AML Patients
- Where
- Zhengzhou
- Age
- 14 years and over
- People
- 130
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06256627 - No phaseTaking peopleThe Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
- Where
- Changsha
- Age
- 1 year and over
- People
- 2,000
- Run by
- Chang-Qing Gao
See details and how to joinNCT02049658 - No phaseTaking peopleBiomarkers for Prediction of Tumor Response to Radiotherapy
- Where
- Shantou
- People
- 100
- Run by
- Chuangzhen Chen
See details and how to joinNCT03744819 - No phaseNot yet taking people in ChinaApplication of LARS Ligament in Bone Prosthesis Replacement
- Where
- Zhengzhou
- People
- 100
- Run by
- Henan Cancer Hospital
See details and how to joinNCT05616182 - No phaseNot yet taking people in ChinaApplication of 3D Printed Prosthesis in Limb Salvage Surgery for Bone Tumors
- Where
- Zhengzhou
- People
- 80
- Run by
- Henan Cancer Hospital
See details and how to joinNCT05616195 - No phaseNot yet taking people in ChinaApplication of Antiosteoporosis Therapy in Osteolysis
- Where
- Zhengzhou
- People
- 100
- Run by
- Henan Cancer Hospital
See details and how to joinNCT05617846 - No phaseTaking peopleAssessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction
- Where
- Beijing
- People
- 300
- Run by
- Peking University People's Hospital
See details and how to joinNCT06211166 - No phaseTaking peopleInternational Chronic Myeloid Leukemia Pediatric Study
- Where
- Hong Kong
- Age
- Up to 18 years
- People
- 750 worldwide
- Run by
- Poitiers University Hospital
See details and how to joinNCT01281735 - Phase 3Taking peopleOndansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
- Where
- Guangzhou
- Age
- 6 months to 18 years
- People
- 376
- Run by
- Yizhuo Zhang
See details and how to joinNCT06208917 - No phaseTaking peopleThe Pathogenesis and Prognostic Factors of Lymphoma
- Where
- Shanghai
- People
- 2,000
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06203652